GSK3B and early-onset autosomal dominant Alzheimer disease: It has also been demonstrated that inhibition of GSK3β can reduce the accumulation of Aβ in the body to a certain extent and can alleviate the reduction of spatial learning and memory in transgenic animals with Alzheimer’s disease (Ding et al., 2008).